Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Post-operative Radiotherapy for Intraparotid Metastatic Cutaneous Squamous Cell Carcinoma

NCT07337161 is registered in ClinicalTrials.gov with David Palma as lead sponsor.

NCT NCT07337161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07337161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Post-operative Radiotherapy for Intraparotid Metastatic Cutaneous Squamous Cell Carcinoma
Lead sponsor
David Palma
Phase
Not applicable
Overall status
Recruiting
Start date
October 21, 2025
Completion date
September 1, 2035
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous, head and neck cancer squamous cell carcinoma